The CATALINA Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorWim Janssens
About this trial
The CATALINA study is a prospective cohort study embedded within CICERO (Collaboration In COPD ExaceRbatiOns, a European Respiratory Society supported Clinical Research Collaboration), designed to collect standardised, longitudinal clinical data and biological samples in 20 centres across Europe and beyond.
Eligibility criteria
Qualifiers
Age 18 years and older
Established diagnosis of COPD by medical doctor (based on clinical history OR pulmonary function test with an FEV1/FVC < 0.7)
Current hospitalization with suspicion of an acute exacerbation of COPD (AECOPD)
Inclusion within 48 hours post hospital admission
Disqualifiers
Patients unwilling or unable to comply with study procedures
Patients not requiring treatment with systemic corticosteroids, antibiotics or both as a minimum therapy for the index AECOPD
Patients with a confirmed positive test result for COVID19, or those highly suspected based on clinical examination
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Wim Janssens
Lead sponsor
KU Leuven
Sponsor institution
European Respiratory Society
Collaborator
AstraZeneca
Collaborator
Roche Pharma AG
Collaborator
GlaxoSmithKline
Collaborator
Source ClinicalTrials.gov